International Stem Cell Corp (ISCO) earnings · rev $5.0M
International Stem Cell Corp (ISCO) is a biotechnology company listed on US.
This ISCO earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported ISCO revenue for 2026-06-30 was $5.0M. Net income was -$291.0K. ISCO currently screens at market cap $880.5K.
When the next ISCO 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
Period-over-period revenue change is not in cache for ISCO. We will not invent a beat or miss.
Not investment advice. Full ISCO research stays on the stock page; the tape stays on the quote page.
Not investment advice.